Tradipitant is a selective human substance P/neurokinin-1 receptor antagonist approved for the prevention of vomiting induced by motion in adults.
Vanda also sells sleep disorder drug Hetlioz, which reached the market in 2014, and relapsing multiple sclerosis treatment ...
Jefferies analysts envision a steady launch curve that could ultimately drive meaningful sales from people who are ...
Pharmaceutical Technology on MSN
FDA approves Vanda Pharmaceuticals’ motion sickness drug Nereus
The US Food and Drug Administration (FDA) has approved Vanda Pharmaceuticals’ Nereus (tradipitant) for the prevention of ...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading higher Wednesday after the company announced it received FDA ...
The FDA has approved tradipitant (Nereus), an oral NK-1 receptor antagonist, for preventing motion-induced vomiting in adults ...
Don’t tell Neil Armstrong, but giant leaps for mankind may leave astronauts feeling a little queasy. In a new experiment, aerospace engineers at the University of Colorado Boulder will work with ...
Vanda Pharmaceuticals has received approval from the U.S. Food and Drug Administration (FDA) for its drug tradipitant, ...
Woman's World on MSN
How to get rid of motion sickness fast and prevent queasiness on long drives
If you know you're likely to get sick, you can buy ginger chews or candies ahead of time. You might also consider preparing ginger tea in advance to help get rid of motion sickness once you're on the ...
Motion sickness sufferers will know all too well how feelings of nausea can linger even after movement has stopped. But researchers in China may have found a way to speed up recovery — listen to happy ...
A new study explored why the severity of motion sickness varies from person to person by investigating sources of cybersickness during VR use. A new study led by Head of the Rokers Vision Laboratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback